Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in the Treatment of Patients With Mild Atopic Dermatitis
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- ISGA
研究概览
简要总结
Atopic dermatitis is a common disease affecting millions worldwide. A common associated symptom in this population is pruritus. We seek to investigate the use of an natural, over-the-counter cosmeceutical to help this population
详细描述
There are many treatment options available for atopic dermatitis yet many patients still suffer from the underlying symptomatology. It is important to explore other treatment alternatives to help this population.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 12 Years 至 75 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •age greater than 12 years, diagnosis of atopic dermatitis for longer than 2 years, investigator's static global assessment score of either 2 or 3, and initial worst itch numerical rating scale (WI-NRS) for itch greater than 4.
排除标准
- •the use of topical or systemic corticosteroids within 28 days of entering the study, the use of any other non-emollient therapy within 28 days of entering the study,nursing, and pregnancy
研究组 & 干预措施
3% Kanuka Oil Cream
3% kanuka oil cream will be applied topically to the affected area twice a day for 28 days
干预措施: 3% kanuka oil (Other)
1% Hydrocortisone Cream
1% Hydrocortisone Cream will be applied topically to the affected area twice a day for 28 days
干预措施: 3% kanuka oil (Other)
结局指标
主要结局
ISGA
时间窗: 28 days
Investigator scale to determine imporvement in condition
WI-NRS
时间窗: 28 days
Scale generated by patient's responses to survey questions to assess improvement in itch
次要结局
未报告次要终点